In-vitro and In-vivo Functional Observation Studies to Establish Therapeutic Potential of Alpha-ketoglutarate Against Methotrexate Induced Liver Injury

Overview

Journal Biomed J

Publisher Elsevier

Specialty General Medicine

Date 2021 Nov 5

PMID 34736875

Citations 2

Authors

Lalita Mehra

Aditi Bhattacharya

Harish Rawat

Amit Kumar

Abhinav Jaimini

Gaurav Mittal

Affiliations

Soon will be listed here.

Abstract

Background: Methotrexate (MTX) is widely used in chemotherapy but its associated hepatotoxicity is a major complication, limiting its use. This study evaluates possible therapeutic effect of oral alpha-ketoglutarate (AKG) supplementation against MTX-induced hepatotoxicity.

Methods: HepG2 cells were used to evaluate in-vitro cyto-protection conferred by AKG against MTX induced cytotoxicity. For in-vivo animal study, rats were divided into three groups. Group-I served as control. Group-II animals were administered single intraperitoneal injection of MTX (20 mg/kg/body weight), while Group-III received MTX as in group-II followed by oral AKG (2 gm/kg body weight) for 5 days. Tc-Mebrofenin hepatobiliary study was performed under a gamma camera to determine real time functional status of rats' livers. Multiple parameters concerning hepatic mebrofenin uptake and excretion, including T and T in control and treated animals were determined. Biochemical analysis of the liver homogenate in terms of hepatic enzyme activities in serum, antioxidant status, tissue factor activity, tissue collagen content and histological analysis of the liver tissue were also done.

Results: AKG supplementation significantly reversed MTX induced derangement in activities of serum liver enzymes [ALT and ALP (p = 0.003); AST (p = 0.005)], antioxidant status [LPO and GSH (p = 0.005); CAT (p = 0.004)], tissue factor activity (p = 0.005) and tissue collagen content (p = 0.005). Functional imaging confirmed that hepatic retention and fractional biliary excretion were significantly abnormal in MTX treated group (T: 234 s ± 40 s; T: 846sec ± 32sec) as compared to AKG supplemented group (T: 144 s ± 35sec; T: 468sec ± 27sec). Hepatic extraction fraction (HEF) was 92.2 ± 1.8%, 48.7 ± 2.6% and 69.8 ± 4.3% in control, MTX and AKG supplemented rats respectively.

Conclusion: Tc-mebrofenin imaging strongly suggests therapeutic action of AKG in protecting liver damage by MTX in rats. Functional imaging parameters correlated well with biochemical and histopathological findings.

Citing Articles

Combination of Vitamin C and Curcumin Safeguards Against Methotrexate-Induced Acute Liver Injury in Mice by Synergistic Antioxidant Effects.

Hasan Khudhair D, Al-Gareeb A, Al-Kuraishy H, El-Kadem A, Elekhnawy E, Negm W Front Med (Lausanne). 2022; 9:866343.

PMID: 35492324 PMC: 9047671. DOI: 10.3389/fmed.2022.866343.

Greek gods and the double-edged sword of liver regeneration.

Kattner A Biomed J. 2021; 44(5):515-520.

PMID: 34715410 PMC: 8640535. DOI: 10.1016/j.bj.2021.10.010.

References

de Graaf W, van Lienden K, van Gulik T, Bennink R . (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med. 2010; 51(2):229-36. DOI: 10.2967/jnumed.109.069724. View

Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2):55-63. DOI: 10.1016/0022-1759(83)90303-4. View

Rojkind M . A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem. 1985; 33(8):737-43. DOI: 10.1177/33.8.2410480. View

Meister A, Anderson M . Glutathione. Annu Rev Biochem. 1983; 52:711-60. DOI: 10.1146/annurev.bi.52.070183.003431. View

TALSTAD I . An analysis of the one-stage prothrombin time. Haemostasis. 1985; 15(5):310-7. DOI: 10.1159/000215165. View

Sokolowska M, Oleszek A, Wlodek L . Protective effect of alpha-keto acids on the oxidative hemolysis. Pol J Pharmacol. 2000; 51(5):429-34. View

Dabek M, Kruszewska D, Filip R, Hotowy A, Pierzynowski L, Wojtasz-Pajak A . alpha-Ketoglutarate (AKG) absorption from pig intestine and plasma pharmacokinetics. J Anim Physiol Anim Nutr (Berl). 2006; 89(11-12):419-26. DOI: 10.1111/j.1439-0396.2005.00566.x. View

Yiang G, Chou P, Hung Y, Chen J, Chang W, Yu Y . Vitamin C enhances anticancer activity in methotrexate‑treated Hep3B hepatocellular carcinoma cells. Oncol Rep. 2014; 32(3):1057-63. PMC: 4121419. DOI: 10.3892/or.2014.3289. View

Butenas S, Orfeo T, Mann K . Tissue factor in coagulation: Which? Where? When?. Arterioscler Thromb Vasc Biol. 2009; 29(12):1989-96. PMC: 2783287. DOI: 10.1161/ATVBAHA.108.177402. View

10.

Bezerra F, Rezende A, Rodrigues S, Almeida M . [Thiobarbituric acid reactive substances as an index of lipid peroxidation in sevoflurane-treated rats.]. Rev Bras Anestesiol. 2009; 54(5):640-9. DOI: 10.1590/s0034-70942004000500004. View

11.

Liu Y, Lange R, Langanky J, Hamma T, Yang B, Steinacker J . Improved training tolerance by supplementation with α-Keto acids in untrained young adults: a randomized, double blind, placebo-controlled trial. J Int Soc Sports Nutr. 2012; 9(1):37. PMC: 3467174. DOI: 10.1186/1550-2783-9-37. View

12.

Liu S, He L, Yao K . The Antioxidative Function of Alpha-Ketoglutarate and Its Applications. Biomed Res Int. 2018; 2018:3408467. PMC: 5884300. DOI: 10.1155/2018/3408467. View

13.

Krishnamurthy G, Krishnamurthy S . Cholescintigraphic measurement of liver function: how is it different from other methods?. Eur J Nucl Med Mol Imaging. 2006; 33(10):1103-6. DOI: 10.1007/s00259-006-0182-7. View

14.

Cetinkaya A, Bulbuloglu E, Belge Kurutas E, Kantarceken B . N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats. Med Sci Monit. 2006; 12(8):BR274-8. View

15.

Malhi H, Bhargava K, Afriyie M, Volenberg I, Schilsky M, Palestro C . 99mTc-mebrofenin scintigraphy for evaluating liver disease in a rat model of Wilson's disease. J Nucl Med. 2002; 43(2):246-52. View

16.

Uraz S, Tahan V, Aygun C, Eren F, Unluguzel G, Yuksel M . Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity. Dig Dis Sci. 2007; 53(4):1071-7. DOI: 10.1007/s10620-007-9949-3. View

17.

Krishnamurthy S, Krishnamurthy G . Technetium-99m-iminodiacetic acid organic anions: review of biokinetics and clinical application in hepatology. Hepatology. 1989; 9(1):139-53. DOI: 10.1002/hep.1840090123. View

18.

Wu J, Schiff K . Sarcoidosis. Am Fam Physician. 2004; 70(2):312-22. View

19.

Harrison A, Pierzynowski S . Biological effects of 2-oxoglutarate with particular emphasis on the regulation of protein, mineral and lipid absorption/metabolism, muscle performance, kidney function, bone formation and cancerogenesis, all viewed from a healthy ageing perspective.... J Physiol Pharmacol. 2008; 59 Suppl 1:91-106. View

20.

Mittal G, Singh T, Kumar N, Bhatnagar A, Tripathi R, Tulsawani R . Radiolabeling and dose fixation study of oral alpha-ketoglutarate as a cyanide antidote in healthy human volunteers. Clin Toxicol (Phila). 2010; 48(6):509-15. DOI: 10.3109/15563650.2010.496371. View